Which of the following groups is at increased risk for the utilization of glucose?

Which of the following groups is at increased risk for the utilization of glucose?

• A. Healthy full-term infants
• B. Sick infants, including preterm and SGA
• C. Infants with adequate nutrition
• D. Neonates with strong immune systems

Answer: (B)

The group identified as sick infants, including those who are preterm and small for gestational age (SGA), is recognized as being at an increased risk for the utilization of glucose due to several factors. These infants often experience stress that can lead to metabolic disturbances, making them more susceptible to fluctuations in blood sugar levels. Sick infants may have compromised hepatic function, altered hormone levels, and increased energy demands as their bodies work to cope with health challenges, all of which can magnify the need for glucose. Moreover, preterm infants often have immature metabolic pathways and reduced glycogen stores, making them more likely to utilize available glucose rapidly and possibly develop hypoglycemia. In contrast, healthy full-term infants, those with adequate nutrition, and neonates with robust immune systems typically maintain stable glucose levels and are less likely to experience the same metabolic complications. They have sufficient glycogen stores and metabolic reserves to manage their glucose needs effectively without the increased risk seen in the sick or compromised groups.

The group identified as sick infants, including those who are preterm and small for gestational age (SGA), is recognized as being at an increased risk for the utilization of glucose due to several factors. These infants often experience stress that can lead to metabolic disturbances, making them more susceptible to fluctuations in blood sugar levels.

Sick infants may have compromised hepatic function, altered hormone levels, and increased energy demands as their bodies work to cope with health challenges, all of which can magnify the need for glucose. Moreover, preterm infants often have immature metabolic pathways and reduced glycogen stores, making them more likely to utilize available glucose rapidly and possibly develop hypoglycemia.

In contrast, healthy full-term infants, those with adequate nutrition, and neonates with robust immune systems typically maintain stable glucose levels and are less likely to experience the same metabolic complications. They have sufficient glycogen stores and metabolic reserves to manage their glucose needs effectively without the increased risk seen in the sick or compromised groups.